It’s natural to want to buy into a rising stock, so pursuing uptrends as a market strategy has a name: momentum investing. It is the art of following the upward trends. Momentum investing has its supporters and critics, as do all investment styles. While past performance does not guarantee future returns, it is a useful indicator to look out for. With that in mind, we used TipRanks’ database to identify two stocks that have a strong buy analyst consensus rating and significant upside potential – on top of impressive recent gains. Let’s take a closer look. Identiv (INVE) The first Momentum inventory we’ll look at, Identiv, is a technology company that provides online solutions for authentication and security systems. Identiv’s products protect the identity of users and prevent malware and other malicious attacks in the IoT world. The importance and value of this niche is evident in the company’s share growth over the past year. INVE is up 65% since the start of the year, and longer term, the stock is up 404% over the past 12 months. The strong stock growth was accompanied by strong sales growth. The company posted revenue growth of 31% year over year to $ 24.8 million in the fourth quarter of 20, with solid prospects for the future. At the beginning of the first quarter, the company had backlog of $ 10.5 million, up 121% year over year. The growth was driven by increases in the company’s RFID segment, which grew over 100% year over year, and in the identity segment, which grew 53% year over year. While sales were solid, earnings declined. The EPS was positive in the third quarter, but turned negative in the fourth quarter, which equates to a net loss of 5 cents per share and misses the expectation of an EPS gain of 1 cent. Investors weren’t too concerned about the loss of profit. Identiv’s historic earnings pattern is to post a fourth quarter loss after a third quarter profit, and its fourth quarter 20 loss was 7 cents per share lower than last year. Management has sought to capitalize on the company’s rising stock value by launching a public offering of shares earlier this month. The offering of 3.78 million shares at $ 10.65 each closed on April 12 and raised over $ 40 million before costs. There’s a lot to do here to get an analyst’s attention, and B. Riley’s 5-star analyst Craig Ellis has started reporting on this stock with a Buy rating and a target price of $ 21, which is on Indicating upside potential of ~ 50% for a year. (To view Ellis’ track record, click here.) “We believe the recent capital increase is transformative and will accelerate growth from 10% in the last two years to + 20% as the company expands its RFID IoT portfolio The net proceeds indicate additional sales potential of $ 50 million with current GMs, “said Ellis. The analyst added, “We believe that INVE’s custom commitment, design and prototype model is strong and that CY22’s revenue conversion is likely to be led by RFID IoT, where sales rose 100% year over year in Q3 20 and 4Q20 and CY21TD’s backlog is robust. The success of early adopters in healthcare, consumer electronics, and medical devices could impact INVE’s high volume industries, enriching growth. “Ellis is not an outlier in his view of this stock; There are 3 recent valuations here, all of which are for sale, making the analyst consensus a unanimous strong buy. The stock is priced at $ 14.04 with an average target of $ 17.33 indicating 23% growth for the coming year. (See INVE stock analysis on TipRanks) Tronox (TROX) Next, Tronox is a miner and maker of specialty metals used in the manufacture of titanium chemicals. The company mines titanium ores and zirconium and uses them to produce titanium dioxide and chemical sand, both essential components of industrial dyes. The company’s products are found in a number of everyday products, including paints, papers, and plastics. Useful by-products of the manufacturing process include caustic soda and gypsum. While the industry lacks the hallmark of high tech, it’s still vital to the modern economy, and that fact has resulted in Tronox’s stock appreciation of 37% year-to-date. For the past 12 months, earnings on the stock were 224%. For the full year 2020, Tronox posted sales of $ 2.76 billion, up 4.5% from 2019. Fourth quarter 20 results show that revenue is accelerating – fourth quarter revenue of $ 783 million increased by 13.6% compared to the previous year. The company saw its titanium dioxide sales volume grow 8% year over year in the fourth quarter, indicating improved global demand as the world economy re-opened. In the future, Tronox expects a further increase in titanium dioxide sales in the range of 11% to 15% for the first quarter 21. With this in mind, BMO analyst John McNulty has listed TROX as one of its top picks for 2021. “Rarely can we remember a time when the stars were aligned in such a way that the risk / return indicated a dramatic upside potential with a relatively low risk – the current outlook for TiO2 and TROX is one of those times. TiO2 is set to tighten steadily over the next two to three years, resulting in higher volumes and higher prices, ”said McNulty. The analyst summarized: “We listed TROX as one of our top picks for 2021 for a number of reasons, including our belief that the strength of the cycle would surprise investors in the short term on the volume side and medium term on the side.” Price page. “Consistent with this bullish outlook, McNulty is outperforming TROX stock (i.e. buying it), and its target price of $ 29 implies 45% one-year upside potential. (To see McNulty’s track record, click here Analysts’ consensus on this stock is not unanimous – but crucial. Ratings are rated 4 to 1 in favor of buy versus hold for a strong buy consensus rating. Average price target of $ 24.40 indicates one Upward trend of 22% for the next 12 months. (See TROX stock analysis on TipRanks.) To find good ideas for trading stocks at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly introduced tool that provides all the insights incorporated into the shares of TipRanks Disclaimer: The opinions expressed in this article are those of the featured analysts only, and the content is intended for informational purposes only be used. It is very important that you do your own analysis before making any investment.